A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening  by Jeremy, Jamie Y. et al.
A bioabsorbable (polyglactin), nonrestrictive, external
sheath inhibits porcine saphenous vein graft thickening
Jamie Y. Jeremy, PhDa
Richard Bulbulia, FRCSb
Jason L. Johnson, MSca
Patricia Gadsdon, BScc
Vikram Vijayan, FRCSb
Nilima Shukla, PhDa
Frank C. T. Smith, FRCSb
Gianni D. Angelini, FRCSa
J. Y. Jeremy
Objective: External, nonrestrictive, macro-porous polyester stents prevent neointima
formation in porcine vein grafts and have been proposed as a therapeutic approach
to the prevention of late vein graft failure. These stents are nonbiodegradable and
therefore may promote long-term foreign body problems including infection and
inflammation. The effect of external macro-porous biodegradable (polyglactin)
sheaths on neointimal and medial thickening in porcine vein grafts was therefore
investigated.
Methods: Bilateral saphenous vein–carotid artery interposition grafting was per-
formed in white Landrace pigs (n  8) with external placement of polyglactin
(Vicryl) sheaths (8 mm in diameter) on 1 side, with the contralateral side acting as
a control. One month after surgery, grafts were explanted and wall dimensions
measured on histological sections using computer-aided planimetry, and an immu-
nocytochemical appraisal was carried out.
Results: All grafts were patent at explantation. Polyglactin sheaths significantly
reduced intimal thickness, medial thickness, and the percentage of proliferating cells
compared with unsheathed controls. There was a pronounced accumulation of
macrophages, giant cells, endothelial cells, and microvessels within and surrounding
the biodegradable sheath compared with controls.
Conclusions: A nonrestrictive, biodegradable (polyglactin), external sheath reduces
medial and intimal thickening in experimental saphenous vein grafts, possibly
through inflammatory cell–mediated angiogenesis. If subsequent long-term studies
confirm preservation of this beneficial effect, once the sheath biodegrades, this
approach may have an advantage over the permanent polyester stent when applied
clinically.
Autologous saphenous vein remains widely used in coronary arterybypass surgery1 and is the graft material of choice in lower limbarterial reconstructive surgery.2 However, the effectiveness ofsaphenous vein grafts is limited by patency rates approaching50% at 10 years after surgery.1,3 Although 10% to 15% of graftsfail due to early thrombotic occlusion, the majority occlude due to
progressive medial thickening and neointimal hyperplasia and subsequent superim-
posed atherosclerosis.1-3 Furthermore, there is no intervention apart from aggressive
lipid lowering4 that has proved successful in ameliorating late vein graft failure.5
It has previously been demonstrated that placement of an external, macro-porous,
nonrestrictive, polyester stent reduces neointima formation in porcine vein grafts.6
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However, significant concerns remain as to the application
of such external stents in arteriovenous bypass grafts in
humans. Long-term vein graft support with polyester may
elicit foreign body and mechanical complications, known to
be associated with the implantation of prosthetic material.7-9
Furthermore, because neointima formation in vein grafts
occurs within 1 month after implantation, long-term support
may not be necessary.10 A possible means of avoiding these
complications is to employ an absorbable external sheath
that remains intact for at least 1 month but then is subse-
quently biodegraded. One material that fulfils these criteria
is polyglactin 910 (Vicryl; Ethicon Inc, Somerville, NJ), a
copolymer of glycoside and L-lactide and absorbable ma-
terial used as suture material in herniorraphy and ophthal-
mic surgery and in protecting traumatized solid intra-ab-
dominal organs.11-13 Absorption has been reported to be
complete between 56 and 70 days postimplantation.11-13 We
therefore investigated the effect of a polyglactin, nonrestric-
tive (8 mm), external sheath on neointima formation in a
porcine model of saphenous vein carotid artery interposition
grafting.
Materials and Methods
Surgical Procedures
Studies were performed using white Landrace pigs (n  8, weight
22-28 kg), which received humane care in accordance with the
Home Office Animals (Scientific Procedures) Act of 1986.14 Ap-
proval for the study was also obtained from the Internal Review
Board of the University of Bristol. Animals were subjected to
premedication, anesthesia, and autologous saphenous vein into
common carotid interposition bypass grafting by a modification of
the method described previously.6 In brief, 10-cm segments of
long saphenous vein were dissected using a no-touch technique
and stored in an isoosmotic sodium chloride solution (0.9 g/L)
containing 2 IU/mL heparin and 50 g/mL glyceryltrinitrate at
room temperature (23°C) until needed. Both common carotid
arteries were exposed and vascular clamps applied proximally and
distally after intravenous injection of heparin (2 IU/mL). On each
side, 3-cm segments of artery were excised and both cut ends
beveled to 45°. Appropriate lengths of reversed saphenous vein
were similarly beveled and anastomosed end-to-end with the ar-
teries using continuous 7-0 Prolene sutures (Ethicon Inc, Somer-
ville, NJ). Sheets of Vicryl mesh (Ethicon Inc) were fashioned into
8-mm diameter tubes (sheaths) with continuous 5-0 Vicryl sutures
(Figure 1) and applied to 1 graft as an external support, covering
both anastomoses and 1 cm of proximal and distal common carotid
artery. The contralateral grafts remained unstented as controls. Use
of distal or proximal portions of vein and the sides externally
stented were randomized. Neck and leg wounds were closed in
layers and the animals recovered and fed a normal chow diet.
After 4 weeks the animals were reanesthetized and the grafts
explanted and pressure-fixed ex vivo at 100 mm Hg with a 6%
paraformaldehyde in phosphate-buffered saline solution (PBS)
containing 2% sucrose for 10 minutes. The grafts were then
postfixed in the same solution for 24 hours before being transferred
to PBS and processed for wax embedding. Transverse sections (5
m) were taken from 6 equidistant points along each graft,
mounted on glass slides, and stained with Alcian blue Miller’s
elastic stain and van Gieson (EVG) stain and hematoxylin and
eosin (H&E) staining.
Morphometric Analysis
Vessel wall dimensions were measured by computer-aided planim-
etry with an Olympus BH-2 microscope with a color video camera
system and Microscale TM/TC image analysis system (Digithurst
Ltd, Royston, Herts, UK).
The area enclosed by the endothelium and the internal elastic
lamina defined the intima, and the area between the internal and
external elastic lamina defined the media. Luminal encroachment
was defined as the percentage of the area enclosed by the internal
elastic lamina occupied by the intima. Luminal, intimal, and me-
dial perimeters and areas were computed using the luminal bound-
ary and internal and external elastic laminae as delimiters, and
mean values were then calculated for all sections from the same
graft. Average intimal, medial, and total vessel wall thickness was
derived from the area and perimeter data for 5 sections from each
graft, assuming that the sections consisted of circular profiles,
which was valid because the tissues were fixed at normal perfusion
pressures.
Immunocytochemistry
Sections were dewaxed, rehydrated, and treated with hydrogen
peroxide in methanol to remove endogenous peroxidase and sec-
tions treated with horse serum were diluted 1 in 3 with Tris-
buffered saline (TBS), pH 7.4, then drained and incubated over-
night at 4°C with the following antibodies: (1) for vascular smooth
muscle cells (VSMCs): monoclonal mouse anti-alpha actin clone
1A4 (Dako, High Wycombe, UK) diluted 1:500 with TBS. For
macrophage staining, sections were treated with trypsin and then
incubated with mouse monoclonal MAC387 (Dako) diluted 1:50
with TBS. For proliferating cell nuclear antigen (PCNA), sections
were microwaved in 10 mmol/L citrate buffer, pH 6, quenched in
1 in 3 horse serum in TBS, and then incubated with PCNA
antibody diluted 1 in 75 overnight at 4°C. After incubation with
primary antibodies, sections were washed and treated with 1 in 400
Figure 1. The polyglactin (Vicryl) sheath (below) compared with
the external polyester stent (above), both of which are 8 mm in
diameter. Previous studies have established that the polyester
stent inhibits saphenous vein graft thickening in the pig model.
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biotinylated goat anti-mouse immunoglobulin and then with
streptavidin biotin complex/horseradish peroxidase (Strept/ABC/
HRPO [Dako]). For endothelial cells, sections were incubated with
horse serum diluted 1 in 3 with 20 mmol/L Hepes buffer, pH 7.5,
drained, and incubated overnight at 4°C with biotinylated anti-
Griffonia Simplicifolia, lectin 1 isolectin B4 (Vector Laboratories,
Peterborough, UK) diluted to 15 g/mL with 20 mmol/L Hepes
buffer, pH 7.5, again followed by Strept/ABC/HRPO (Dako).
Visualization was achieved using 3,3'-diaminobenzidine, and then
after counterstaining with diluted hematoxylin, sections were de-
hydrated and mounted. The PCNA sections were counterstained
with diluted H&E before dehydration and mounting. For dual
labeling of lectin and PCNA, sections were treated as above for
endothelial cells and followed by microwave treatment and incu-
bation in PCNA at 1 in 75 overnight. They were then treated with
goat anti-mouse immunoglobulin G (Dako) at 1 in 50 followed by
alkaline phosphatase anti-alkaline phosphatase (Dako) and visual-
ized using Vector Blue kit (Vector Laboratories). The sections
were counterstained using nuclear fast red.
The total number of cells positive for PCNA was counted in 4
fields at40 magnification, which abutted the lumen and included
the neointima and inner media. Five sections per graft were as-
sessed. The number of PCNA-positive cells was expressed as a
percentage of the total cell number (PCNA index).
Data Analysis and Statistics
Data were collated and analyzed using Microsoft Excel (Microsoft
Corporation, Redmond, Wash) and nonparametric statistical anal-
ysis carried out using an Intercooled Stata 8 statistics package
(Stata Corporation, College Station, Tex). Although data did not
appear to be skewed, Barlett’s test for equality of variance (a
necessary assumption for a 1-way analysis of variance [ANOVA])
was significant, indicating that nonparametric methods of analysis
was required. Thus, values are expressed as median and interquar-
tile ranges and graphically as whisker box plots. The Kruskal-
Wallis test, a nonparametric version of ANOVA, was applied and
then the Wilcoxon matched-pair signed-rank test was used to test
for statistical significance.
Results
All data cited in this section are the medians (25th and 75th
interquartile ranges) (Figure 2). All grafts were patent at
explantation (1 month after implantation). Vicryl sheath
Figure 2. Planimetric analysis of saphenous vein grafts fitted with polyglactin external sheaths 1 month after
implantation. a, Luminal area (LA); b, neointimal thickness (NT); c, medial thickness (MIT); and d, % cells positively
stained for PCNA (PCNA index). Data are expressed as box and whisker plots, n  8. Asterisk denotes statistical
significance when comparing sheathed with unsheathed saphenous vein grafts (Wilcoxon matched-pair signed-
rank test with a Bonferroni adjustment).
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material was still clearly visible in the outer adventitial
region (Figures 3 and 4). In vein grafts fitted with a Vicryl
sheath there was a statistically significant decrease in neo-
intimal thickness (0.11 [0.07-0.12] mm) compared with
unsheathed grafts (0.19 [0.15-0.215] mm) and in medial
thickness (0.175  0.165-0.2] mm) compared with un-
sheathed controls (0.285 [0.26-0.305] mm) (Figures 2 and
3). There was no statistically significant difference in the
lumenal areas when comparing sheathed with unsheathed
controls (Figure 2). In vein grafts fitted with a Vicryl sheath
there was a statistically significant decrease in cells that
were positively stained for PCNA in the medial/intimal
region (9.85% [8.9%-11.6%]) compared with unsheathed
vein grafts (33% [30%-39%]) (Figure 2). The diameter of
the sheathed grafts from the external elastic lamina to the
lumenal endothelium was significantly greater in un-
sheathed grafts (7.9 [7.7-8.1] mm) compared with grafts
fitted with a Vicryl sheath (6.1 [5.9-6.3] mm). It is notable
that the diameter of the sheathed graft was markedly less
than the diameter of the sheath (ie, 8 mm), indicating that
the sheath has not become tight fitting at 1 month.
Immunocytochemical studies indicated that the space
between graft and sheath had become organized into a
neoadventitia that contained microvessels, particularly in
the region closer to the stent (Figure 4, a). There were large
numbers of macrophages within and around the sheath
(Figure 4, b) as well as giant cells (Figure 4, d). The
neoadventitia and the sheath material contained large num-
bers of both endothelial cells (Figure 4, c) and VSMCs
(Figure 4, d). Microvessels in the inner region of the sheath
appeared to be connected with those immediately outside it
(Figure 4, d). Cells within the sheath material displayed a
high degree of PCNA positivity, indicating active prolifer-
ative processes (angiogenesis) occurring within the sheath.
Discussion
The present study demonstrates that placement of an exter-
nal, macro-porous, loose-fitting, polyglactin sheath inhibits
Figure 3. Representative photomicrographs of H&E-stained transverse sections of a control vein graft (a and c) and
a vein graft fitted with a polyglactin external nonrestrictive sheath (b and d). The scale bar in panels (a) and (b)
represent 1 mm and the scale bar in panels (c) and (d) represents 250 m. L, Lumen; NI, neointima; M, media; NA,
neoadventitia; IEL, internal elastic lamina; EEL, external elastic lamina.
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Figure 5. Comparison of EVG staining of the medial region of pig saphenous vein grafts: (A) fitted with an external
Vicryl sheath and (B) unsheathed controls 1 month after graft implantation. Scale bar  20 m. There was no
indication of edema, disorganization, or inflammation in the medial region of the externally sheathed graft
demonstrating that medial quality is maintained or improved by the sheath.
Figure 4. Photomicrographs of pig vein grafts fitted with an external polyglactin stent demonstrating the following.
a, The distribution of microvessels within the biodegradable sheath and immediately outside it indicated with white
arrows. Scale bar represents 100 m. b, Immunostaining for MAC387 showing large numbers of macrophages (dark
brown) associated with the sheath material as well as in the neoadventitia (NA) with few, if any, macrophages
present in the media (M), however. Scale bar represents 100 m. c, Dual labeling of endothelial cells (blue arrow)
and cells positive for PCNA (red arrow) within the sheath material. Scale bar  50 m. d, Immunostaining for
-actin (brown) and giant cells (purple). Scale bar  50 m. Note the microvessel passing from inside to the
outside of the sheath in close proximity to the giant cell and VSMCs that have infiltrated the sheath.
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neointimal and medial thickening in porcine vein grafts to
the same degree as a nonbiodegradable polyester external
stent of identical diameter.6 External sheaths made of bio-
degradable materials could therefore be used clinically to
prevent saphenous vein graft thickening and reduce graft
failure following arterial reconstructive surgery.
For the external polyester stent to prevent neointimal
thickening, it had to be loose-fitting and macro-porous.14
The polyglactin sheath employed in the present study ful-
filled both criteria. Tight-fitting polyester stents (5 mm),
which prevented early distension of the vein graft, did not
prevent neointima formation or graft thickening,15 whereas
8-mm stents were optimally effective in the pig.16 Tight-
fitting biodegradable sheaths prevented disorganization,
edema, and neutrophil accumulation17-19 (Figure 5) but not
neointimal hyperplasia.20 With the 8-mm polyester stent,
the space between the graft and the stent becomes organized
into a cell-rich “neoadventitia,” abundant with microves-
sels.6,14 Within this “neovasa vasorum,” these microvessels
infiltrate through the spaces within the stent and were con-
tinuous with the vasculature outside the stent.6,14 With a
restrictive stent, not surprisingly, this microvessel-rich neo-
adventitia was absent.15,16
It was proposed, therefore, that the loose-fitting external
polyester stent allows for the development and promotion of
a neoadventitia in the space between the graft and the stent.
In turn, this allows for the development of microvessels that
may obviate graft wall hyperplasia through the prevention
of graft hypoxia.5 In the present study, the polyglactin
sheath was also 8 mm in diameter (and therefore loose-
fitting when placed around the vein graft) and also promoted
the formation of microvessels, particularly in and around the
sheath material. This consolidates the possible importance
of initial nonrestriction in promoting angiogenesis and mi-
crovessel formation and hence prevention of neointima for-
mation in vein grafts.
Porosity was also found to be important in mediating the
effect of the polyester external stent. Polytetrafluoroethyl-
ene (micro-porous) stents (also 8 mm in diameter) not only
promoted neointimal and medial thickening but also pre-
vented microvessel formation.14 Porosity appears to be cru-
cial since it allows the microvessels that form in the neo-
adventitia to connect with the vasculature outside the stent
allowing a fully integrated blood flow to the graft. This
nonporous stent, by preventing this connection, effectively
negates the positive effect of angiogenesis.14 The polygla-
ctin sheath studied here is also highly porous, allowing the
free infiltration of microvessels while still allowing the
formation of a microvessel-rich neoadventitia.
Another striking facet of the polyglactin sheath was that
macrophages and giant cells, as well as endothelial cells,
VSMCs, and microvessels, had accumulated within and
around the material. Because macrophages release a battery
of factors that promote angiogenesis,21,22 it is reasonable to
suggest that the enhanced microvessel formation observed
with loose-fitting external stents is initiated and maintained
by the accumulation of inflammatory cells in this region. As
VSMCs were seen in large numbers in and around the
polyglactin sheath, it is also reasonable to postulate that the
resident intrasheath macrophages set up a gradient of higher
concentrations of chemotactic substances within the stent
relative to that within the graft wall. This, in turn, would
promote the migration of VSMCs out toward the sheath and
therefore prevent neointima formation. It is perhaps impor-
tant to note that the distance between the graft and the
sheath (and the macrophages associated with it) may itself
be crucial to the impact of the external sheath. Indeed,
Bambang and colleagues20 found in vein grafts with tight
fitting Vicryl sheaths that neointimal hyperplasia was not
inhibited and there was an accumulation of macrophages in
the medial region. This close proximity of macrophages,
through the release of remodeling factors, may elicit the
undesirable effect of VSMC proliferation in the media/
intima and explain, in part, why loose-fitting stents and/or
sheaths are effective.
It is also likely that the sheath has a direct physical
impact on graft biology. Although initially the graft does
not interact with the loose-fitting sheath (the sheath is 8 mm
in diameter and the graft 5 mm when fully distended), the
formation of a neoadventitia renders the graft physically
continuous with the medial/intimal component of the graft.
At 1 month, the external elastic lamina is still some distance
from the sheath, which is separated from it by the adventitia,
indicating that the sheath has not become constrictive, a
facet that has been shown to promote neointima formation.
The present study also demonstrates that the Vicryl
sheath was still present at 1 month after implantation, which
is consistent with a previous report that Vicryl meshes are
completely absorbed in vivo after 5 months.23 Thus, longer-
term studies (over 6 months) are required to determine
whether positive effect of the Vicryl sheath persists after its
complete absorption.
From a clinical perspective, the use of a polyester exter-
nal stent may significantly increase the risk of graft infec-
tion, a serious complication of peripheral arterial recon-
structive surgery.7-9 Indeed, there is evidence that use of
biodegradable materials has a lower incidence of surgical
wound infection.24-27 In the long term, the nonbiodegrad-
able polyester stent may elicit other problems, in particular
chronic inflammation and fibrosis. Employment of a biode-
gradable external sheath may avoid these recognized and
potential problems while achieving the primary objective of
preventing graft thickening. Additionally, this external Vi-
cryl sheath may represent a means of delivering drugs (eg,
losartan and paclitaxel) that prevent graft thickening locally
to the graft. Thus, at implantation, the space between the
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graft and the sheath could be filled with a pluronic gel
containing appropriate drugs that may augment the inhibi-
tion of graft thickening and associated pathology. Loose-
fitting, highly porous, biodegradable, external vascular
sheaths may therefore represent a safer and more applicable
prosthesis for use in arterial reconstructive surgery. Further
longer-term studies are required to consolidate these hy-
potheses.
We are grateful to Dr Christine Rogers for advice on statistical
analyses.
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